Department of Radiology, University Medical Center Utrecht, the Netherlands.
Department of Vascular Medicine, University Medical Center Utrecht, the Netherlands.
Eur J Prev Cardiol. 2021 Oct 13;28(12):1386-1391. doi: 10.1177/2047487320919895. Epub 2020 Apr 28.
Abdominal aortic calcifications were already ubiquitous in ancient populations from all continents. Although nowadays generally considered as an innocent end stage of stabilised atherosclerotic plaques, increasing evidence suggests that arterial calcifications contribute to cardiovascular risk. In this review we address abdominal aortic calcification from an evolutionary perspective and review the literature on histology, prevalence, risk factors, clinical outcomes and pharmacological interventions of abdominal aortic calcification.
The design of this study was based on a literature review.
Pubmed and Embase were systematically searched for articles on abdominal aortic calcification and its synonyms without language restrictions. Articles with data on histology, prevalence, risk factors clinical outcomes and/or pharmacological interventions were selected.
Abdominal aortic calcification is highly prevalent in the general population and prevalence and extent increase with age. Prevalence and risk factors differ between males and females and different ethnicities. Risk factors include traditional cardiovascular risk factors and decreased bone mineral density. Abdominal aortic calcification is shown to contribute to arterial stiffness and is a strong predictor of cardiovascular events and mortality. Several therapies to inhibit arterial calcification have been developed and investigated in small clinical trials.
Abdominal aortic calcification is from all eras and increasingly acknowledged as an independent contributor to cardiovascular disease. Large studies with long follow-up must be carried out to show whether inhibition of abdominal aortic calcification will further reduce cardiovascular risk.
腹部主动脉钙化在来自各大洲的古代人群中已经普遍存在。尽管现在普遍认为它是稳定的动脉粥样硬化斑块的终末期表现,但越来越多的证据表明,动脉钙化会增加心血管风险。在这篇综述中,我们从进化的角度探讨了腹部主动脉钙化,并回顾了关于其组织学、患病率、危险因素、临床结局和药物干预的文献。
本研究的设计基于文献综述。
系统地检索了 Pubmed 和 Embase 上关于腹部主动脉钙化及其同义词的文章,不限制语言。选择了有关于组织学、患病率、危险因素、临床结局和/或药物干预数据的文章。
腹部主动脉钙化在普通人群中患病率很高,且随着年龄的增长而增加。患病率和危险因素在男性和女性以及不同种族之间存在差异。危险因素包括传统心血管危险因素和骨密度降低。腹部主动脉钙化被证明会导致动脉僵硬,是心血管事件和死亡率的强有力预测因素。已经开发并在小型临床试验中研究了几种抑制动脉钙化的疗法。
从各个时代开始,腹部主动脉钙化已被越来越多地认为是心血管疾病的一个独立危险因素。必须进行具有长期随访的大型研究,以证明抑制腹部主动脉钙化是否会进一步降低心血管风险。